Hall Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.1M Buy
2,588
+1,346
+108% +$1.38M 0.97% 32
2026
Q1
$1.16M Buy
1,242
+1,024
+470% +$1.04M 0.41% 50
2025
Q4
$234K Buy
+218
New +$208K 0.09% 93

Other funds holding LLY

Hall Capital Management's LLY Position: Q2 2026 in Review

Hall Capital Management increased its Eli Lilly (LLY) stake by 108% in Q2 2026, buying an estimated $1.38M and bringing the position to 2,588 shares worth $3.1M. The position accounts for 0.97% of the portfolio, ranked #32.

Hall Capital Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hall Capital Management held 2,588 shares of Eli Lilly worth $3.1M as of Q2 2026.
  • Hall Capital Management bought 1,346 Eli Lilly shares in Q2 2026, an estimated $1.38M.
  • Eli Lilly made up 0.97% of Hall Capital Management's portfolio in Q2 2026, its #32 holding.
  • Hall Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hall Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.